Researchers say that GS-6207, Gilead's first-in-class capside inhibitor, can remain in our body's system for up to 24 weeks.
Native Americans and rural providers say homophobia and stigma will hinder the fight against HIV in states like Oklahoma.
Once on the brink of death, Simba Say overcame an AIDS to become a professional model — and found a million reasons to love.
Drug-resistant strains of HIV are becoming more common. Here’s the 411 on what you need to know to suppress the viral uprising.
The generation that faced the AIDS epidemic alone is now finding answers to aging with HIV.
The vice president and director of public policy at amfAR knows what needs to change in HIV education.
Due to underreporting, HIV specialists often believe diarrhea is disappearing among poz folks. It's not.
